R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds

R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
A study of chemotherapy medicines produced by 10 companies found that, on average, each drug produced seven times as much revenue for its manufacturer as it cost in research and development.

Industry says it costs about $2.7 billion to bring a cancer drug to market. But oncologists who ran the numbers put the average closer to $650 million. Drugs are priced way too high, the doctors say.

(Image credit: BrianAJackson/iStockphoto/Getty Images)